Tecogen Announces Fourth Quarter and Year-End 2025 Results
Rhea-AI Summary
Tecogen (NYSE American: TGEN) reported 2025 revenues of $27.07M, up 19.7% year-over-year, and a 2025 net loss of $8.25M versus a $4.76M loss in 2024. Product sales rose 105.5% to $9.13M, while gross margin fell to 36.3% from 43.6% due to higher labor and material costs. The company used $9.91M in operating cash, raised $17.40M in financing, and held $12.43M cash at year-end. A conference call is scheduled for March 18, 2026 at 9:30 AM ET.
Positive
- Revenue +19.7% year-over-year to $27.07M
- Products revenue +105.5% to $9.13M
- Raised $17.40M in financing during 2025, supporting liquidity
Negative
- Net loss widened to $8.25M in 2025 from $4.76M in 2024
- Gross margin declined to 36.3% from 43.6% (730 bps decline)
- Operating expenses increased 25.4% to $18.07M in 2025
- Used $9.91M in cash from operations during 2025
News Market Reaction – TGEN
On the day this news was published, TGEN declined 29.58%, reflecting a significant negative market reaction. Argus tracked a peak move of +5.2% during that session. Argus tracked a trough of -32.1% from its starting point during tracking. Our momentum scanner triggered 23 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $37M from the company's valuation, bringing the market cap to $88M at that time. Trading volume was exceptionally heavy at 7.7x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
TGEN gained 3.27% with mixed earnings, while peers showed smaller, mixed moves: FCEL +1.74%, NVX +0.16%, EAF +1.18%, SDST -1.74%, NEOV 0%. This points to a company-specific reaction.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Earnings date set | Neutral | -10.3% | Set FY 2025 earnings release and call date and logistics. |
| Nov 12 | Q3 2025 earnings | Negative | -6.0% | Q3 2025 results with higher revenue but wider loss and margin compression. |
| Oct 31 | Q3 call scheduled | Neutral | +4.1% | Announced Q3 2025 earnings release timing and conference call details. |
Earnings-related communications have often been followed by negative price moves, especially when margins and losses were highlighted.
Over the past several months, Tecogen has repeatedly focused on financial updates and investor communications. A Nov 12, 2025 Q3 2025 earnings release highlighted revenue growth but also a larger net loss and margin compression, and the stock fell 5.96%. Two conference‑call scheduling announcements on Oct 31, 2025 and Feb 26, 2026 framed upcoming results; the latter coincided with a 10.34% decline. Against this backdrop, the current FY 2025 report, which combines strong revenue growth with wider losses and weaker margins, continues a theme of growth accompanied by profitability pressure.
Market Pulse Summary
The stock dropped -29.6% in the session following this news. A negative reaction despite revenue growth fits prior patterns where earnings news drew selling. FY 2025 revenue increased to $27.07M, but net loss deepened to $8.25M and gross margin compressed, echoing Q3 2025, which saw a -5.96% move after highlighting higher losses. With operating cash outflows of $9.91M, investors could focus on profitability and cash usage as key risks that might outweigh the expanding products and services footprint.
Key Terms
goodwill financial
long-lived asset impairment financial
adjusted EBITDA financial
AI-generated analysis. Not financial advice.
Abinand Rangesh, CEO of Tecogen, commented "during the upcoming call, I will provide some significant positive updates that will include the scale of the Vertiv opportunity pipeline for our chillers, the status of our own data center opportunities and an upcoming pilot project.
On other positive news, our revenue grew
NORTH BILLERICA, MA / ACCESS Newswire / March 17, 2026 / Tecogen Inc. (NYSE American:TGEN), a leading manufacturer of clean energy products, reported revenues of
Key Takeaways
Net Loss and Earnings Per Share
Net loss for the quarter ended December 31, 2025 was
$3.99 million compared to a net loss of$1.19 million for the same period of 2024, an increase of$2.81 million , due to the impairment of goodwill and long-lived assets, increased operating expenses and decreased gross profit from our Services segments. EPS for the quarters ended December 31, 2025 and 2024 was a loss of$0.13 /share and$0.05 /share, respectively.Net loss for the year ended December 31, 2025 was
$8.25 million compared to a net loss of$4.76 million in 2024, an increase of$3.49 million , due to decreased gross profit for our Services segment due to increased labor and material costs, increased operating costs and the goodwill and long-lived asset impairment recognized in the year ended December 31, 2025. EPS for the years ended December 31, 2025 and 2024 was a loss of$0.30 /share and$0.19 , respectively.
Loss from Operations
Loss from operations for the quarter ended December 31, 2025 was
$4.14 million compared to a loss from operations of$1.14 million for the same period in 2024, an increase of$3.00 million , due to the impairment of goodwill and long-lived assets, increased operating expenses and decreased gross profit from our Services segments.Loss from operations for the year ended December 31, 2025 was
$8.24 million compared to a loss from operations of$4.53 million for the same period in 2024, an increase of$3.71 million , due to the impairment of goodwill and long-lived assets, increased operating expenses and decreased gross profit from our Services segments.
Revenues
Revenues for the quarter ended December 31, 2025 were
$5.32 million compared to$6.08 million for the same period in 2024, a12.5% decrease.Products revenues in the quarter ended December 31, 2025 were
$0.46 million compared to$1.44 million for the same period in 2024, a decrease of68.1% . The decrease in revenue during the quarter ended December 31, 2025 is due to a reduction in chiller and cogeneration revenue.Services revenues in the quarter ended December 31, 2025 were
$4.46 million , compared to$4.08 million for the same period in 2024, an increase of9.3% due to a$0.36 million increase in revenues from existing contracts and a$0.01 million increase in revenues from the acquired Aegis maintenance contracts.Energy Production revenues in the quarter ended December 31, 2025 were
$395 thousand compared to$550 thousand for the same period in 2024, an decrease of28.3% . The decrease in Energy Production revenue is due to the expiration of contracts late in 2024 and decreased run hours at certain energy production sites.
Revenues for the year ended December 31, 2025 were
$27.07 million compared to$22.62 million for the same period in 2024, an increase of19.7% year over year.Products revenues in the year ended December 31, 2025 were
$9.13 million compared to$4.44 million for the same period in 2024 an increase of105.5% . The increase in revenue during the year ended December 31, 2025 is due to increased chiller and cogeneration sales. The relocation to our new facility in April 2024 constrained our manufacturing capacity, which impacted product revenues during the second and third quarters of 2024.Services revenues in the year ended December 31, 2025 were
$16.62 million compared to$16.07 million for the same period in 2024, an increase of3.4% . The increase in revenue during the year ended December 31, 2025 is due to the addition of$0.82 million in revenues from existing contracts, offset by a$0.27 million decrease in revenue from Aegis maintenance contracts.Energy Production revenues in the year ended December 31, 2025 were
$1.32 million , compared to$2.10 million for the same period in 2024, a decrease of37.0% . The decrease in Energy Production revenue is due to the expiration of contracts late in 2024 and decreased run hours at certain energy production sites.
Gross Profit
Gross profit for the quarter ended December 31, 2025 was
$1.96 million compared to$2.73 million in the same period in 2024. Gross margin decreased to36.8% in the quarter ended December 31, 2025 compared to45.0% for the same period in 2024. The decrease in gross margin was driven by increased labor and material costs in our Services segment, increased labor cost in our Products segment and lower Energy Production margins.Gross profit for the year ended December 31, 2025 was
$9.82 million compared to$9.87 million in the same period of 2024. Gross margin decreased to36.3% in the year ended December 31, 2025 compared to43.6% for the same period in 2024. The decrease in gross margin was driven by increased labor and material costs in our Services segment and lower Energy Production margins in the year ended December 31, 2025.
Operating Expenses
Operating expenses increased
$2.22 million , or57.4% , to$6.10 million in the quarter ended December 31, 2025 compared to$3.87 million in the same period in 2024, due to the$1.11 million goodwill and long-lived asset impairment and increases in payroll, benefits, recruitment costs, freight costs and sales commissions.Operating expenses increased
$3.67 million , or25.4% , to$18.07 million in the year ended December 31, 2025 compared to$14.40 million in the same period in 2024 due to the$1.11 million goodwill and long-lived asset impairment and increases in payroll, benefits, recruitment costs, freight costs and sales commissions.
Adjusted EBITDA was negative
Conference Call Scheduled for March 18, 2026, at 9:30 am ET
Tecogen will host a conference call on March 18, 2026 to discuss the fourth quarter results beginning at 9:30 am eastern time. To listen to the call please dial (877) 407-7186 within the U.S. and Canada, or +1 (201) 689-8052 from other international locations. Participants should ask to be joined to the Tecogen Fourth Quarter and Year-End 2025 earnings call. Please begin dialing 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the "News and Events" section under "About Us." The earnings conference call will be webcast live. To view the associated slides, register for and listen to the webcast, go to https://ir.tecogen.com/ir-calendar. Following the call, the recording will be archived for 14 days.
The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback, dial (877) 660-6853 within the U.S. and Canada, or (201) 612-7415 from other international locations and use Conference Call ID#: 13752231.
About Tecogen
Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel in key markets in North America. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.
Forward Looking Statements
This press release and any accompanying documents, contain "forward-looking statements" which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," "target," "potential," "will," "should," "could," "likely," or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.
In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and on our Current Reports on Form 8-K, under "Risk Factors", among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.
In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation. We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.
Tecogen Media & Investor Relations Contact Information:
Abinand Rangesh
P: 781-466-6487
E: Abinand.Rangesh@tecogen.com
TECOGEN INC.
CONSOLIDATED BALANCE SHEETS
(unaudited)
ASSETS | December 31, 2025 | December 31, 2024 | ||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 12,430,287 | $ | 5,405,233 | ||||
Accounts receivable, net | 4,280,991 | 6,026,545 | ||||||
Unbilled revenue | 138,020 | 398,898 | ||||||
Inventory, net | 10,949,697 | 9,634,005 | ||||||
Prepaid and other current assets | 1,086,310 | 680,565 | ||||||
Total current assets | 28,885,305 | 22,145,246 | ||||||
Property, plant and equipment, net | 1,609,321 | 1,738,036 | ||||||
Right of use assets - operating leases | 1,490,094 | 1,730,358 | ||||||
Right of use assets - finance leases | 1,434,080 | 452,390 | ||||||
Intangible assets, net | 2,146,503 | 2,513,189 | ||||||
Goodwill | 1,248,442 | 2,346,566 | ||||||
Other assets | 176,358 | 166,474 | ||||||
TOTAL ASSETS | $ | 36,990,103 | $ | 31,092,259 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Related party notes payable | $ | - | $ | 1,548,872 | ||||
Accounts payable | 3,381,545 | 4,142,678 | ||||||
Accrued expenses | 2,814,150 | 2,890,886 | ||||||
Deferred revenue, current | 1,530,977 | 6,701,131 | ||||||
Operating lease obligations, current | 538,641 | 430,382 | ||||||
Finance lease obligations, current | 280,265 | 85,646 | ||||||
Acquisition liabilities, current | 677,162 | 902,552 | ||||||
Unfavorable contract liabilities, current | 44,433 | 113,449 | ||||||
Total current liabilities | 9,267,173 | 16,815,596 | ||||||
Long-term liabilities: | ||||||||
Deferred revenue, net of current portion | 3,265,886 | 1,165,951 | ||||||
Operating lease obligations, net of current portion | 1,004,488 | 1,341,789 | ||||||
Finance lease obligations, net of current portion | 992,285 | 325,235 | ||||||
Acquisition liabilities, net of current portion | 826,757 | 1,008,760 | ||||||
Unfavorable contract liability, net of current portion | 160,902 | 309,390 | ||||||
Total liabilities | 15,517,491 | 20,966,721 | ||||||
Commitments and contingencies | - | - | ||||||
Stockholders' equity: | ||||||||
Tecogen Inc. stockholders' equity: | ||||||||
Common stock, | 29,847 | 24,950 | ||||||
Additional paid-in capital | 78,216,467 | 57,845,289 | ||||||
Unearned compensation | (712,019 | ) | - | |||||
Accumulated deficit | (55,888,649 | ) | (47,639,894 | ) | ||||
Total Tecogen Inc. stockholders' equity | 21,645,646 | 10,230,345 | ||||||
Noncontrolling interest | (173,034 | ) | (104,807 | ) | ||||
Total stockholders' equity | 21,472,612 | 10,125,538 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 36,990,103 | $ | 31,092,259 | ||||
TECOGEN INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Three Months Ended | ||||||||
December 31, 2025 | December 31, 2024 | |||||||
Revenues | ||||||||
Products | $ | 460,522 | $ | 1,441,909 | ||||
Services | 4,462,823 | 4,083,492 | ||||||
Energy production | 394,652 | 550,121 | ||||||
Total revenues | 5,317,997 | 6,075,522 | ||||||
Cost of sales | ||||||||
Products | 492,219 | 995,921 | ||||||
Services | 2,527,701 | 2,009,762 | ||||||
Energy production | 340,669 | 335,392 | ||||||
Total cost of sales | 3,360,589 | 3,341,075 | ||||||
Gross profit | 1,957,408 | 2,734,447 | ||||||
Operating expenses | ||||||||
General and administrative | 4,090,960 | 2,928,287 | ||||||
Selling | 585,163 | 503,145 | ||||||
Research and development | 307,426 | 226,843 | ||||||
Gain on disposition of assets | (1,250 | ) | (4,111 | ) | ||||
Goodwill impairment | 1,113,129 | 217,295 | ||||||
Total operating expenses | 6,095,428 | 3,871,459 | ||||||
Loss from operations | (4,138,020 | ) | (1,137,012 | ) | ||||
Other income (expense) | ||||||||
Other income (expense), net | 90,409 | (11,509 | ) | |||||
Interest expense | (38,697 | ) | (30,762 | ) | ||||
Gain on sale of marketable securities | 3,687 | - | ||||||
Unrealized gain on marketable securities | 85,988 | - | ||||||
Total other income (expense), net | 141,387 | (42,271 | ) | |||||
Loss before provision for state income taxes | (3,996,633 | ) | (1,179,283 | ) | ||||
Provision for state income taxes | - | 465 | ||||||
Consolidated net loss | (3,996,633 | ) | (1,179,748 | ) | ||||
Loss (income) attributable to the non-controlling interest | 2,853 | (6,319 | ) | |||||
Loss attributable to Tecogen Inc. | $ | (3,993,780 | ) | $ | (1,186,067 | ) | ||
Net loss per share - basic | $ | (0.13 | ) | $ | (0.05 | ) | ||
Net loss per share - diluted | $ | (0.13 | ) | $ | (0.05 | ) | ||
Weighted average shares outstanding - basic | 29,839,305 | 24,893,739 | ||||||
Weighted average shares outstanding - diluted | 29,839,305 | 24,893,739 | ||||||
Three Months Ended | ||||||||
December 31, 2025 | December 31, 2024 | |||||||
Non-GAAP financial disclosure (1) | ||||||||
Net loss attributable to Tecogen Inc. | $ | (3,993,780 | ) | $ | (1,186,067 | ) | ||
Interest expense, net | 38,697 | 30,762 | ||||||
Income taxes | - | 465 | ||||||
Depreciation & amortization, net | 256,145 | 134,039 | ||||||
EBITDA | (3,698,938 | ) | (1,020,801 | ) | ||||
Stock-based compensation | 138,171 | 41,082 | ||||||
Gain on sale of marketable securities | (3,687 | ) | - | |||||
Unrealized gain on marketable securities | (85,988 | ) | - | |||||
Inventory write down | 110,488 | 70,530 | ||||||
Goodwill and long-lived asset impairment | 1,113,129 | 217,295 | ||||||
Adjusted EBITDA | $ | (2,426,825 | ) | $ | (691,894 | ) | ||
TECOGEN INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Years Ended | ||||||||
December 31, 2025 | December 31, 2024 | |||||||
Revenues | ||||||||
Products | $ | 9,133,450 | $ | 4,443,996 | ||||
Services | 16,616,523 | 16,074,870 | ||||||
Energy production | 1,323,737 | 2,100,670 | ||||||
Total revenues | 27,073,710 | 22,619,536 | ||||||
Cost of sales | ||||||||
Products | 6,097,501 | 3,014,655 | ||||||
Services | 10,202,774 | 8,432,876 | ||||||
Energy production | 948,927 | 1,301,832 | ||||||
Total cost of sales | 17,249,202 | 12,749,363 | ||||||
Gross profit | 9,824,508 | 9,870,173 | ||||||
Operating expenses: | ||||||||
General and administrative | 13,522,035 | 11,356,406 | ||||||
Selling | 2,267,247 | 1,880,903 | ||||||
Research and development | 1,166,744 | 961,837 | ||||||
Loss (gain) on sale of assets | 183 | (12,181 | ) | |||||
Long-lived asset impairment | 15,005 | - | ||||||
Goodwill impairment | 1,098,124 | 217,295 | ||||||
Total operating expenses | 18,069,338 | 14,404,260 | ||||||
Loss from operations | (8,244,830 | ) | (4,534,087 | ) | ||||
Other income (expense) | ||||||||
Interest and other income (expense) | 151,711 | (26,814 | ) | |||||
Interest expense | (150,289 | ) | (90,304 | ) | ||||
Gain on the sale of marketable securities | 3,687 | - | ||||||
Unrealized gain on marketable securities | 10,993 | - | ||||||
Total other expense, net | 16,102 | (117,118 | ) | |||||
Loss before income taxes | (8,228,728 | ) | (4,651,205 | ) | ||||
State income tax provision | 20,615 | 22,565 | ||||||
Consolidated net loss | (8,249,343 | ) | (4,673,770 | ) | ||||
Loss (income) attributable to the noncontrolling interest | 588 | (86,468 | ) | |||||
Net loss attributable to Tecogen Inc. | $ | (8,248,755 | ) | $ | (4,760,238 | ) | ||
Net loss per share - basic | $ | (0.30 | ) | $ | (0.19 | ) | ||
Net loss per share - diluted | $ | (0.30 | ) | $ | (0.19 | ) | ||
Weighted average shares outstanding - basic | 27,233,143 | 24,861,190 | ||||||
Weighted average shares outstanding - diluted | 27,233,143 | 24,861,190 | ||||||
Years Ended | ||||||||
December 31, 2025 | December 31, 2024 | |||||||
Non-GAAP financial disclosure (1) | ||||||||
Net income loss attributable to Tecogen Inc. | $ | (8,248,755 | ) | $ | (4,760,238 | ) | ||
Interest expense | 150,289 | 90,304 | ||||||
Provision for income taxes | 20,615 | 22,565 | ||||||
Depreciation & amortization, net | 877,675 | 553,783 | ||||||
EBITDA | (7,200,176 | ) | (4,093,586 | ) | ||||
Stock-based compensation | 348,029 | 172,987 | ||||||
Realized gain on marketable securities | (3,687 | ) | - | |||||
Unrealized gain on marketable securities | (10,993 | ) | - | |||||
Inventory writedown | 110,488 | 70,530 | ||||||
Goodwill and long-lived asset impairment | 1,113,129 | 217,295 | ||||||
Adjusted EBITDA | $ | (5,643,210 | ) | $ | (3,632,774 | ) | ||
(1) Non-GAAP Financial Measures
In addition to reporting net income, a U.S. generally accepted accounting principle ("GAAP") measure, this news release contains information about Adjusted EBITDA (net income (loss) attributable to Tecogen Inc adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges including abandonment of certain intangible assets), which is a non-GAAP measure. The Company believes Adjusted EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results. Adjusted EBITDA is not calculated through the application of GAAP. Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.
TECOGEN INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
For the Years Ended | ||||||||
December 31, 2025 | December 31, 2024 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Consolidated loss | $ | (8,249,343 | ) | $ | (4,673,770 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation, accretion and amortization, net | 877,675 | 553,783 | ||||||
Loss (gain) on sale of assets | 183 | (12,181 | ) | |||||
Provision for credit losses | 62,958 | 146,010 | ||||||
Provision for inventory reserve | 110,488 | 70,530 | ||||||
Unrealized gain on investment securities | (10,993 | ) | - | |||||
Gain on the sale of investments | (3,687 | ) | - | |||||
Stock-based compensation | 348,029 | 172,987 | ||||||
Goodwill and long-lived asset impairment | 1,113,129 | 217,295 | ||||||
Non-cash interest expense | 43,476 | 45,025 | ||||||
Changes in operating assets and liabilities: | ||||||||
(Increase) decrease in: | ||||||||
Accounts receivable | 1,682,596 | 608,929 | ||||||
Inventory, net | (1,426,182 | ) | 848,884 | |||||
Unbilled revenue | 260,879 | 859,634 | ||||||
Prepaid expenses and other current assets | (405,745 | ) | (319,926 | ) | ||||
Other non-current assets | 464,576 | 510,723 | ||||||
Increase (decrease) in: | ||||||||
Accounts payable | (761,131 | ) | (371,736 | ) | ||||
Accrued expenses | (76,736 | ) | 386,257 | |||||
Deferred revenue | (3,070,219 | ) | 5,850,265 | |||||
Other current liabilities | (871,627 | ) | (832,162 | ) | ||||
Net cash provided by (used in) operating activities | (9,911,674 | ) | 4,060,547 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchases of property and equipment | (400,781 | ) | (969,163 | ) | ||||
Proceeds on sale of property and equipment | 4,290 | 51,400 | ||||||
Distributions to noncontrolling interest | (67,639 | ) | (96,974 | ) | ||||
Net used in investing activities | (464,130 | ) | (1,014,737 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from follow-on offering, net of transaction costs | 18,105,100 | - | ||||||
(Repayment of) proceeds from related party note | (1,076,956 | ) | 1,000,000 | |||||
Finance lease principal payments | (324,065 | ) | (62,847 | ) | ||||
Proceeds from exercise of stock options | 696,779 | 71,000 | ||||||
Net cash provided by financing activities | 17,400,858 | 1,008,153 | ||||||
Change in cash and cash equivalents | 7,025,054 | 4,053,963 | ||||||
Cash and cash equivalents, beginning of the year | 5,405,233 | 1,351,270 | ||||||
Cash and cash equivalents, end of the year | $ | 12,430,287 | $ | 5,405,233 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid for interest | $ | 183,354 | $ | 45,278 | ||||
Cash paid for taxes | $ | 20,615 | $ | 22,565 | ||||
Non-cash investing activities | ||||||||
Right-of-use assets acquired under operating leases | $ | 193,480 | $ | 1,650,994 | ||||
Right-of-use assets acquired under finance leases | $ | 1,227,447 | $ | 295,085 | ||||
Aegis acquisition: | ||||||||
Contingent consideration | $ | - | $ | 272,901 | ||||
Non-cash financing activities | ||||||||
Related party note conversion to common stock | $ | 514,148 | $ | - | ||||
SOURCE: Tecogen, Inc.
View the original press release on ACCESS Newswire
FAQ
What were Tecogen (TGEN) full-year 2025 revenues and net loss?
How did Tecogen's products revenue perform in 2025 (TGEN)?
Why did Tecogen (TGEN) gross margin decline in 2025?
How much cash did Tecogen (TGEN) use and raise in 2025?
What drove Tecogen's larger net loss in 2025 (TGEN)?
When is Tecogen's (TGEN) conference call to discuss Q4 and year-end 2025 results?
